Answer
No. It is substrate-reduction therapy that decreases production of certain glycosphingolipids.
Sources for this answer
- Yargesa (miglustat) 100mg Hard Capsulesemc · SmPC Current selected SmPC · Version 6
loading page…
Explore the tools and reference material available on iatroX.
Explore askiatroX